Skip to content
StockMarketAgent
Sector pending / Medical LaboratoriesUpdated 2026-05-10 22:07 UTC

BOM/542918 stock hub

BOM/542918 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BOM/542918is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
61.7M
Bombay Stock Exchange
Market data

Price

Recent price action with selectable time range.

BOM/542918BOM/542918
Loading chart…
In the news

Latest news · BOM/542918

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC-3.7
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BOM/542918 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
155
Groups with data
10
Currency
INR
Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
India
Country code
IN
Employees
24
Employees Change
-7%
Employees Change Percent
-22.58
Enterprise value
INR 44.4M
Exchange
Bombay Stock Exchange
Financial currency
INR
First seen
2026-05-10
Industry
Medical Laboratories
Last refreshed
2026-05-10
Market cap
INR 61.7M
Price
INR 5.97
Price currency
INR
Rev Per Employee
1,567,958.33x
Sic
8071
Symbol
bom/542918
Website
https://gianlifecare.org

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
-15.44%
EV Earnings
-4.66x
EV/EBITDA
68.73x
EV/Sales
1.18x
P/B ratio
0.33x
P/S ratio
1.64x
PE Ratio3 Y
11.69x
PE Ratio5 Y
11.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
EBIT Margin
-16.93%
EBITDA Margin
1.72%
Gross margin
72.79%
Gross Profit
INR 27.4M
Gross Profit Growth
-69.07%
Gross Profit Growth Q
-44.65%
Gross Profit Growth3 Y
-35.17%
Gross Profit Growth5 Y
-16.12%
Net Income
INR -9.5M
Net Income Growth Q
-70.67%
Pretax Margin
-27.51%
Profit Margin
-25.34%
Profit Per Employee
INR -397,292
Roa5y
9.2
Roe5y
18.3
ROIC
-3.74
Roic5y
17.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr1y
-63.46%
Cagr3y
-38.86%
Cagr5y
-5.58%
EPS Growth Q
-70.59
Revenue Growth
-62.82x
Revenue Growth Q
-29.32x
Revenue Growth3 Y
-33.58x
Revenue Growth5 Y
-18.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

14
MetricValue
Cash
INR 74.6M
Debt
INR 57.3M
Debt EBITDA
INR 88.59
Debt Equity
INR 0.31
Equity
INR 187.7M
Interest Coverage
-1.3
Net Cash
INR 17.3M
Net Cash By Market Cap
INR 28.06
Net Cash Growth
-41.56%
Net Debt EBITDA
INR -26.81
Net Debt Equity
INR -0.09
Tangible Book Value
INR 187.7M
Tangible Book Value Per Share
INR 18.15
WACC
5.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-63.43%
200-day SMA
11.11
3Y total return
-77.15%
50-day SMA
6.95
50-day SMA vs 200-day SMA
50under200
5Y total return
-24.94%
All Time High
65.91
All Time High Change
-91.2%
All Time High Date
2022-02-17
All Time Low
5.43
All Time Low Change
6.81%
All Time Low Date
2026-05-06
ATR
0.49
Beta
-0.04
Beta1y
1.03
Beta2y
0.54
Ch YTD
-30.79
High
5.98
High52
17.49
High52 Date
2025-08-11
High52ch
-65.87%
Low
5.7
Low52
5.43
Low52 Date
2026-05-06
Low52ch
9.95%
Ma50ch
-16.56%
Price vs 200-day SMA
-47.79%
RSI
36.74
RSI Monthly
31.97
RSI Weekly
29.03
Sharpe ratio
-2.21x
Sortino ratio
-2.62
Total Return
-0.68%
Tr YTD
-30.79
Tr1m
-6.45%
Tr1w
-3.49%
Tr3m
-42.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
INR -6.4M
Operating Income Growth Q
-61.69
Operating margin
-16.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
4,981,526%
Shares Insiders
51.82%
Shares Institutions
10.57%
Shares Out
10,341,524
Shares Qo Q
-0.94%
Shares Yo Y
0.68%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

43
MetricValue
Average Volume
10,395.8x
Bv Per Share
18.15
Ch1m
-6.45
Ch1w
-3.49
Ch1y
-63.43
Ch3m
-42.52
Ch3y
-77.15
Ch5y
-24.94
Ch6m
-53.15
Change
2.93%
Change From Open
0.51
Close
5.8
Days Gap
2.41
Depreciation Amortization
7,017,250
Dollar Volume
73,395.2
Earnings Date
2026-05-29
EBIT
INR -6.4M
EBITDA
INR 646,250
EPS
INR -0.93
F Score
0
Fiscal Year End
March
Founded
2,018
Income Tax
INR -819,000
Is Primary Listing
1
Last Earnings Date
2026-02-14
Last Report Date
2025-12-31
Last Split Date
2022-03-29
Last Split Type
Forward
Ma150
9.66
Ma150ch
-39.98%
Ma20
6.45
Ma20ch
-10.01%
Next Earnings Date
2026-05-29
Open
5.94
Position In Range
96.43
Price Date
2026-05-08
Price EBITDA
INR 95.53
Ptbv Ratio
0.33
Relative Volume
1.18x
Revenue
37,631,000x
Tax By Revenue
-2.18x
Tr6m
-53.15%
Volume
12,294
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BOM/542918 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/542918 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-63.4%
S&P 500 1Y: n/a
3Y total return
-77.1%
S&P 500 3Y: n/a
5Y total return
-24.9%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BOM/542918?

Insider, institutional, and short-interest positioning.

Institutional ownership
+10.6%
Share of float held by funds and institutions
Insider ownership
+51.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.7%
Negative means the company is buying back shares.
Technical

BOM/542918 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
36.7
Neutral momentum band
Price vs 200-day MA
-47.8%
50/200-day relationship not available
Beta (5Y)
-0.04
Less volatile than the market
Sharpe ratio
-2.21
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BOM/542918

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/542918 stock rating?

bom/542918 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/542918 analysis?

The full report lives at /stocks/bom/542918/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/542918?

The latest report frames bom/542918 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/542918 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

bom/542918 stock profile: metrics, valuation and analysis | 주식시장 AI 에이전트